Galovan Scott Michael has filed 11 insider transactions across 1 company since March 2026.
Most recent transaction: a grant/award of 29481 shares of AVANOS MEDICAL, INC. ($AVNS) on March 13, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 13, 2026 | AVANOS MEDICAL, INC. | $AVNS | Galovan Scott Michael | SVP, Chief Financial Officer | A | Common Stock | 29481 | $0.00 | 139,824.0000 | 46,416,998 | 26.72% | 0.06% |
| March 13, 2026 | AVANOS MEDICAL, INC. | $AVNS | Galovan Scott Michael | SVP, Chief Financial Officer | A | Employee Stock Option (right to buy) | 70115 | $0.00 | 96,697.0000 | 46,416,998 | 263.77% | 0.15% |
| March 13, 2026 | AVANOS MEDICAL, INC. | $AVNS | Galovan Scott Michael | SVP, Chief Financial Officer | A | Common Stock | 29481 | $0.00 | 139,824.0000 | 46,416,998 | 26.72% | 0.06% |
| March 13, 2026 | AVANOS MEDICAL, INC. | $AVNS | Galovan Scott Michael | SVP, Chief Financial Officer | A | Employee Stock Option (right to buy) | 69630 | $0.00 | 96,212.0000 | 46,416,998 | 261.94% | 0.15% |
| March 13, 2026 | AVANOS MEDICAL, INC. | $AVNS | Galovan Scott Michael | SVP, Chief Financial Officer | A | Employee Stock Option (right to buy) | 69630 | $0.00 | 96,212.0000 | 46,416,998 | 261.94% | 0.15% |
| March 13, 2026 | AVANOS MEDICAL, INC. | $AVNS | Galovan Scott Michael | SVP, Chief Financial Officer | A | Common Stock | 29481 | $0.00 | 139,824.0000 | 46,416,998 | 26.72% | 0.06% |
| March 9, 2026 | AVANOS MEDICAL, INC. | $AVNS | Galovan Scott Michael | SVP, Chief Financial Officer | F | Common Stock | 1119 | $13.29 | 110,343.0000 | 46,416,998 | 1.00% | 0.00% |
| March 6, 2026 | AVANOS MEDICAL, INC. | $AVNS | Galovan Scott Michael | SVP, Chief Financial Officer | F | Common Stock | 2041 | $13.79 | 111,462.0000 | 46,416,998 | 1.80% | 0.00% |
| March 6, 2026 | AVANOS MEDICAL, INC. | $AVNS | Galovan Scott Michael | SVP, Chief Financial Officer | F | Common Stock | 1057 | $13.79 | 113,503.0000 | 46,416,998 | 0.92% | 0.00% |
| March 6, 2026 | AVANOS MEDICAL, INC. | $AVNS | Galovan Scott Michael | SVP, Chief Financial Officer | F | Common Stock | 2356 | $13.79 | 114,560.0000 | 46,416,998 | 2.02% | 0.01% |
| March 6, 2026 | AVANOS MEDICAL, INC. | $AVNS | Galovan Scott Michael | SVP, Chief Financial Officer | M | Common Stock | 5907 | $13.79 | 116,916.0000 | 46,416,998 | 5.32% | 0.01% |